{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:25:31Z","timestamp":1787315131852,"version":"build-2736575974"},"reference-count":66,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Several tools have been developed to provide prognostic indicators that are more accurate than chronological age alone because choosing the best treatment for older lymphoma patients is challenging. For older patients with diffuse large B\u2010cell lymphoma (DLBCL), one of these prognostic indicators is patient fitness; its definition has been validated, its assessment is recommended by international guidelines and it is currently integrated into several clinical trials. In terms of fitness, frailty is emerging as a major barrier to curative options for older patients with Hodgkin lymphoma (HL) as well, and the preliminary data now available support geriatric assessment in this setting. This review presents and discusses the robust results on the prognostic value of assessing fitness achieved in DLBCL and the early findings of geriatric studies conducted in HL, including promising novel approaches to defining patient fitness.<\/jats:p>","DOI":"10.1111\/bjh.70290","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T06:21:16Z","timestamp":1766730076000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The importance of assessing the fitness of older patients with newly diagnosed diffuse large B\u2010cell lymphoma and classic Hodgkin lymphoma"],"prefix":"10.1111","volume":"208","author":[{"given":"Vittorio Ruggero","family":"Zilioli","sequence":"first","affiliation":[{"name":"Division of Hematology ASST Grande Ospedale Metropolitano Niguarda  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[{"name":"Hematology Division ASST Spedali Civili di Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Spina","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Immune\u2010Related Tumors Centro di Riferimento Oncologico di Aviano IRCCS  Pordenone Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0979-7883","authenticated-orcid":false,"given":"Francesco","family":"Merli","sequence":"additional","affiliation":[{"name":"Hematology Unit Azienda Unit\u00e0 Sanitaria Locale\u2010IRCCS di Reggio Emilia  Reggio Emilia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Arcari","sequence":"additional","affiliation":[{"name":"Hematology Unit Ospedale Guglielmo da Saliceto  Piacenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Elderly Lymphoma Committee of the Fondazione Italiana Linfomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"National Cancer Institute.Cancer stat facts: Hodgkin lymphoma. [cited 2025 May]. Available from:https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html"},{"key":"e_1_2_12_3_1","unstructured":"National Cancer Institute.Cancer stat facts: non\u2010Hodgkin lymphoma. [cited 2025 May]. Available from:https:\/\/seer.cancer.gov\/statfacts\/html\/nhl.html"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950101)75:1 <357::AID-CNCR2820751318>3.0.CO;2-A"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20107"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103657"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00519-7"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3081"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24490"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.245803"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.494"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx413"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00933"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.6559"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(21)00184-7"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.953142"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02465"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17554"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129499"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004777"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.04.008"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.4158"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.12009"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00843-5"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70069-9"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-202588"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00925"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2024.01.008"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70093_159"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009839"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2425"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70099"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019173"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70110_LBA2"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-157768"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199271"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023789"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12222"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03815.x"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1522435"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28373"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920815)70:4<830::AID-CNCR2820700418>3.0.CO;2-X"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.11.080"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.3058"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-378414"},{"key":"e_1_2_12_47_1","doi-asserted-by":"crossref","unstructured":"BarrettA KirkwoodAA BurtonC CliffordR HendersonR MckayP et\u00a0al.Hodgkin Lymphoma in Older Patients (HOOP)\u2014a European retrospective study. HemaSphere Volume 8: The 13th International Symposium on Hodgkin Lymphoma Abstract Book 2024 pp. 74\u201375.","DOI":"10.1002\/hem3.70012"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7"},{"key":"e_1_2_12_49_1","unstructured":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) Hodgkin lymphoma version 2.2025\u2014January 30 2025."},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13419"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000890896.83681.49"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.278438"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01315-1"},{"issue":"2","key":"e_1_2_12_54_1","first-page":"66","article-title":"Feasibility and efficacy of PET\u2010guided BrECADD in older patients with advanced stange classical Hodgkin lymphoma: the older cohort of the international GHSG HD21 trial","volume":"8","author":"Ferdinandus J","year":"2024","journal-title":"HemaSphere"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0139"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405888"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00204"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019536"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004645"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12736"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02473"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afq034"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy169"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.816421"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2499-4"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12115"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00513-7"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70290","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.70290","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:19:34Z","timestamp":1771035574000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/bjh.70290"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70290","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"2025-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}